FIRST MANHATTAN CO. LLC. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$2,037,000
-13.8%
38,5750.0%0.01%
-28.6%
Q2 2020$2,363,000
-3.8%
38,575
-11.2%
0.01%
-12.5%
Q1 2020$2,457,000
-5.2%
43,450
-4.6%
0.02%
+23.1%
Q4 2019$2,593,000
+6.4%
45,5500.0%0.01%0.0%
Q3 2019$2,437,000
+12.2%
45,550
+25.2%
0.01%
+8.3%
Q2 2019$2,172,000
-4.2%
36,3900.0%0.01%
-7.7%
Q1 2019$2,268,000
-10.8%
36,390
-13.3%
0.01%
-18.8%
Q4 2018$2,543,000
-8.2%
41,980
-11.4%
0.02%
+6.7%
Q3 2018$2,771,000
+56.9%
47,380
+20.3%
0.02%
+50.0%
Q2 2018$1,766,000
+51.1%
39,380
+49.3%
0.01%
+42.9%
Q1 2018$1,169,000
-10.9%
26,380
-12.9%
0.01%0.0%
Q4 2017$1,312,000
-19.8%
30,280
-13.9%
0.01%
-22.2%
Q3 2017$1,636,000
-11.1%
35,180
-5.4%
0.01%
-18.2%
Q2 2017$1,840,000
-14.3%
37,180
-5.1%
0.01%
-15.4%
Q1 2017$2,147,000
-6.4%
39,180
-4.9%
0.01%
-7.1%
Q4 2016$2,293,000
+15.7%
41,180
-5.1%
0.01%
+16.7%
Q3 2016$1,981,000
+14.4%
43,3800.0%0.01%
+9.1%
Q2 2016$1,732,000
+14.7%
43,3800.0%0.01%
+22.2%
Q1 2016$1,510,000
+30.7%
43,380
+61.4%
0.01%
+28.6%
Q4 2015$1,155,000
-1.3%
26,8800.0%0.01%
-12.5%
Q3 2015$1,170,000
+690.5%
26,880
+833.3%
0.01%
+700.0%
Q2 2015$148,000
+32.1%
2,8800.0%0.00%0.0%
Q1 2015$112,000
+0.9%
2,8800.0%0.00%0.0%
Q4 2014$111,000
+9.9%
2,8800.0%0.00%0.0%
Q3 2014$101,000
-85.8%
2,880
-89.0%
0.00%
-75.0%
Q2 2014$709,000
-3.3%
26,300
-7.1%
0.00%
-20.0%
Q1 2014$733,000
+75.4%
28,300
+46.6%
0.01%
+66.7%
Q4 2013$418,000
+7.5%
19,300
-3.5%
0.00%0.0%
Q3 2013$389,000
+18.6%
20,0000.0%0.00%
+50.0%
Q2 2013$328,00020,0000.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2016
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders